Earlier today, Nutra Pharma Corporation (OTCQB: NPHC), the company behind innovative pharmaceutical products such as Nyloxin® and Pet Pain-Away, released a letter to shareholders. In the letter, Rik J. Deitsch, the company’s chief executive officer, gave investors a brief overview of Nutra Pharma’s progress during 2015, as well as its goals and expectations for the […]

The success of any growing business depends on a wide variety of factors, but few decisions can impact a company’s prospects for growth more than choosing the right industry or market niche in which to operate. In a recent article on Entrepreneur.com, Christina Baldassarre outlined the benefits of one of the most intriguing market sectors […]

Nutra Pharma Corp. (OTCQB: NPHC) is introducing new healthcare solutions to the globe. Through ReceptoPharm, a subsidiary, Nutra Pharma is discovering, researching and developing biopharmaceutical products to prevent and/or treat multiple sclerosis (MS), HIV/AIDS, adrenomyeloneuropathy (ADM), herpes, rheumatoid arthritis and pain. Drug Discovery & Development Nutra Pharma is in the business of acquiring, licensing and […]

GTX Corp. (OTC: GTXO) has been at the forefront of 2-way GPS real-time personal location services since it went public in 2008. Since then, it has introduced miniaturized GPS, BLE, and cellular tracking technology that minimizes power consumption. These services and devices can monitor and locate people, pets, vehicles, and more. Headquartered in Los Angeles […]

When combining a traditional restaurant concept with the excitement of innovative entertainment options, membership programs and value cards can make a huge difference to a company’s bottom line. To illustrate this fact, one needs look no further than Dave and Buster’s Entertainment, Inc. (NASDAQ: PLAY), the growing force behind one of the most popular dining […]

Anatole France, who won the Nobel Prize for Literature in 1921, famously said, “Until one has loved an animal, a part of one’s soul remains unawakened.” We know how true that is, because we do love our animals. In Pet Population & Ownership Trends (November 2014), the market research company Packaged Facts reported that about […]

With the recent announcement from Australia’s version of the FDA, the Therapeutic Goods Administration, that pluripotent stem cell manufacturing innovator International Stem Cell Corp. (OTCQB: ISCO) has been cleared to start Phase I/IIa dose escalation clinical trials focused on the safety and efficacy of its human parthenogenetic neural stem cells (ISC-hpNSCs), the company has taken […]

Freedom Leaf, a leading marketing and business resource for the cannabis, industrial hemp, and medical marijuana industries, has its roots in the vision of its founders, representing decades of experience in the marijuana legalization movement. The company does not handle, grow, sell, or dispense marijuana or related products, but rather is a movement marketing company […]

Alternet Systems, Inc. (OTCQB: ALYI) is preparing people for a new age of digital living. The company, which invests in technological tools that enable and expedite commerce, is focused on elevating its customers’ – and partners’ – experience with multichannel payments, digital commerce and predictive analytics. By concentrating on improving efficiency, the company is pushing […]

International Stem Cell Corp., a clinical stage biotech company developing novel stem cell-based therapies, has signed a master clinical research agreement with the Florey Institute of Neuroscience and Mental Health to conduct phase I/IIa clinical trial, dose escalation trial of human parthenogenetic stem cells-derived neural stem cells (ISC-hpNSC) in Parkinson’s disease (PD) patients. ISCO said […]